76168-82-6
76168-82-6 structure
- Name: ramoplanin A2
- Chemical Name: Ramoplanin
- CAS Number: 76168-82-6
- Molecular Formula: C106H170ClN21O30
- Molecular Weight: 2554.066
- Catalog: Signaling Pathways Anti-infection Bacterial
- Create Date: 2018-08-31 17:56:28
- Modify Date: 2024-01-04 13:16:01
-
Ramoplanin is a broad-spectrum lipoglycodepsipeptide antibiotic derived from the Actinoplanes spp with with activity against gram-positive bacteria[1][2].
| Name | Ramoplanin |
|---|---|
| Synonyms |
A 16686A
N-[(3S,6R,9S,15S,18R,21S,24R,27S,30S,33R,36S,39R,42R,45R,48S,49S)-24,42-Bis(3-aminopropyl)-27-benzyl-49-carbamoyl-3-(3-chloro-4-hydroxyphenyl)-18,39-bis[(1R)-1-hydroxyethyl]-30-[(1S)-1-hydroxyethyl ]-15,33,36,45-tetrakis(4-hydroxyphenyl)-9-isobutyl-21-(4-{[2-O-(α-D-mannopyranosyl)-α-D-mannopyranosyl]oxy}phenyl)-6-methyl-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-hexadecaoxo-1-oxa-4,7,1
 0,13,16,19,22,25,28,31,34,37,40,43,46-pentad L-Aspartamide, N-[(3S,6R,9S,15S,18R,21S,24R,27S,30S,33R,36S,39R,42R,45R,48S,49S)-49-(aminocarbonyl)-24,42-bis(3-aminopropyl)-3-(3-chloro-4-hydroxyphenyl)-18,39-bis[(1R)-1-hydroxyethyl]-30-[(1S)-1-h ;ydroxyethyl]-15,33,36,45-tetrakis(4-hydroxyphenyl)-21-[4-[(2-O-α-D-mannopyranosyl-α-D-mannopyranosyl)oxy]phenyl]-6-methyl-9-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-hexade caoxo-27-(phenylmethyl)-1-oxa-4,7,10,13,16,1 ramoplanin A2 A 16686 Antibiotic A 16686 |
| Description | Ramoplanin is a broad-spectrum lipoglycodepsipeptide antibiotic derived from the Actinoplanes spp with with activity against gram-positive bacteria[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Bacteria[1] |
| In Vitro | Ramoplanin exerts its bactericidal activity against gram-positive aerobic and anaerobic bacteria by blocking peptidoglycan synthesis via lipid II[1]. |
| In Vivo | Ramoplanin (100, 500 μg/ml; p.o.; for 8 days) suppresses vancomycin-resistant Enterococcus (VRE) to undetectable level during treatment[1]. Animal Model: Female CF1 mice (25-30 g)[1] Dosage: 100 μg/ml, 500 μg/ml Administration: Oral administration; for 8 days Result: Developed undetectable levels of VRE in stool during treatment. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Melting Point | >218 °C(dec.) |
| Molecular Formula | C106H170ClN21O30 |
| Molecular Weight | 2554.066 |
| Exact Mass | 2552.035156 |
| LogP | -6.39 |
| Index of Refraction | 1.689 |
| Storage condition | -20°C |
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H318 |
| Precautionary Statements | P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | C |
| RIDADR | NONH for all modes of transport |
| RTECS | VE5050000 |